Privigen

Biological CSL Behring
Total Payments
$2.6M
Transactions
2,302
Doctors
893
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2024 $472,445 140 79
2023 $96,313 206 120
2022 $141,999 252 108
2021 $493,220 433 201
2020 $756,734 179 58
2019 $626,795 366 69
2018 $8,874 504 304
2017 $12,613 222 148

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $2.2M 420 82.7%
Consulting Fee $173,172 44 6.6%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $112,191 39 4.3%
Honoraria $78,755 24 3.0%
Food and Beverage $40,476 1,416 1.6%
Travel and Lodging $34,296 105 1.3%
Royalty or License $10,015 1 0.4%
Education $3,045 253 0.1%

Payments by Type

Research
$2.2M
420 transactions
General
$451,950
1,882 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
Randomized Study of Single vs. Multiple Privigen Dose Regimens in Pediatric CIDP CSL Behring $1.3M 3
A Randomized, Multicenter, Double-Blind, Placebo Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of IgPro10 (Intravenous Immunoglobulin, Privigen) for the Treatment of Adults With Systemic Sclerosis CSL Behring $427,388 0
A randomized, openlabel, prospective, multicenter study designed to investigate 2 dose regimens in pediatric subjects 2 to 17 years of age with confirmed or possible CIDP, either previously exposed to IVIG treatment or unexposed to IVIG treatment CSL Behring $181,773 0
Single vs. Multiple Privigen Dose Regimens in Pediatric CIDP CSL Behring $142,440 0
Scleroderma Study CSL Behring $108,433 0
IVIg to Treat BK Viremia in Kidney Transplant Recipients CSL Behring $38,225 0
IgPro103006 - 5 Translations in English, German, French, Italian, & Polish CSL Behring $3,000 1

Top Doctors Receiving Payments for Privigen — Page 3

Doctor Specialty Location Total Records
, MD Internal Medicine Boston, MA $2,186 11
, MD Rheumatology Wichita, KS $2,135 14
, M.D Internal Medicine Ann Arbor, MI $2,092 11
, MD Rheumatology Great Neck, NY $2,029 12
, MD Rheumatology Charleston, SC $2,020 12
, M.D Neurology Lutherville, MD $1,973 1
, MD Hematology & Oncology Cincinnati, OH $1,960 1
, M.D, M.P.H Neurology Lone Tree, CO $1,935 2
, MD Rheumatology Cleveland, OH $1,933 10
, M.D Allergy Pittsburgh, PA $1,932 3
, MD Allergy & Immunology Philadelphia, PA $1,870 1
, M.D Neurology Denver, CO $1,870 1
, M.D Rheumatology Scottsdale, AZ $1,865 11
, MD Internal Medicine Philadelphia, PA $1,852 15
, M.D Internal Medicine Houston, TX $1,611 9
, M.D., MS Neurology East Lansing, MI $1,560 1
, MD Neuromuscular Medicine Pittsburgh, PA $1,560 1
, M.D Allergy & Immunology St Petersburg, FL $1,560 1
, MD Pediatrics New York, NY $1,560 1
, MD Neurology Cordova, TN $1,523 2
, MD Neurology Philadelphia, PA $1,499 1
, MD Rheumatology Birmingham, AL $1,388 7
, MD Rheumatology Nashville, TN $1,320 1
, MD Internal Medicine Los Angeles, CA $1,115 11
, MD Rheumatology Los Angeles, CA $671.49 7
«12345…36»

Manufacturing Companies

Product Information

  • Type Biological
  • Total Payments $2.6M
  • Total Doctors 893
  • Transactions 2,302

About Privigen

Privigen is a biological associated with $2.6M in payments to 893 healthcare providers, recorded across 2,302 transactions in the CMS Open Payments database. The primary manufacturer is CSL Behring.

Payment data is available from 2017 to 2024. In 2024, $472,445 was paid across 140 transactions to 79 doctors.

The most common payment nature for Privigen is "Unspecified" ($2.2M, 82.7% of total).

Privigen is associated with 7 research studies, including "Randomized Study of Single vs. Multiple Privigen Dose Regimens in Pediatric CIDP" ($1.3M).